Search

Elaprase

Elaprase

idursulfase

Manufacturer:

Sanofi

Distributor:

DCH Auriga - Healthcare
Concise Prescribing Info
Contents
Idursulfase
Indications/Uses
Hunter syndrome (mucopolysaccharidosis II). Improves walking capacity in patient ≥5 yr.
Click to view Elaprase detailed prescribing information
Dosage/Direction for Use
IV infusion 0.5 mg/kg once wkly.
Click to view Elaprase detailed prescribing information
Overdosage
View Elaprase overdosage for action to be taken in the event of an overdose.
Special Precautions
Anaphylactic & allergic reactions. Postpone administration in acute resp complications &/or acute cardioresp failure. Pregnancy & lactation. Childn 16 mth to 5 yr.
Click to view Elaprase detailed prescribing information
Adverse Reactions
Hypersensitivity reactions including rash, urticaria, pruritus, flushing, pyrexia & headache; hypoxia; cardiac arrhythmia, pulmonary embolism, cyanosis, resp failure, infection & arthralgia.
Click to view Elaprase detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Elaprase detailed prescribing information
Storage
View Elaprase storage conditions for details to ensure optimal shelf-life.
Description
View Elaprase description for details of the chemical structure and excipients (inactive components).
Action
View Elaprase mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Other Agents Affecting Metabolism
ATC Classification
A16AB09 - idursulfase ; Belongs to the class of enzymes. Used in the treatment of alimentary tract and metabolism problems.
Presentation/Packing
Form
Elaprase inj 2 mg/mL
Packing/Price
3 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in